Bionic

Cybersecurity Acquired asset Dual-Use Technology Founded 2019

Last updated: Apr 28, 2026

Bionic developed runtime-aware application security posture management (ASPM) technology that prioritizes vulnerability remediation through production context and behavior analytics. Acquired by CrowdStrike in 2023.

Visit Website

Company Overview

Bionic developed a sophisticated application security posture management (ASPM) platform that distinguished itself by embedding runtime behavior and production context into vulnerability triage and remediation workflows. Rather than relying solely on static discovery of weaknesses, Bionic's core innovation was mapping what applications actually do in production—API calls, data flows, active threat exposure, library usage patterns—to answer the critical AppSec question: which of the thousands of known vulnerabilities actually matter for this application in this environment. This context-driven approach to prioritization directly reduced noise and enabled security teams to focus remediation on vulnerabilities with genuine exploitability and business impact.

The company was founded in Israel in 2019 and grew to become a recognizable player in the expanding ASPM category alongside established vendors and emerging competitors. CrowdStrike acquired Bionic in 2023, integrating the platform's runtime-context technology into its broader cloud security and application protection suite. The acquisition validated the market thesis that application-centric security analytics would be essential as software supply chains and cloud-native deployments created unprecedented complexity in software risk.

Bionic's dual-use relevance is substantial and defensible. Commercial enterprises use application security to reduce operational risk and comply with software assurance standards. Defense and critical infrastructure sectors benefit directly from the same runtime-aware, context-driven vulnerability prioritization—particularly in mission-critical systems where software failures or exploits have operational consequences. The technology pattern of mapping active software behavior to identify exploitable pathways is directly applicable to both secure software development practices and software assurance in high-consequence defense environments. The acquisition by CrowdStrike—a major provider of security infrastructure to both commercial and government customers—further amplifies this dual-use pathway.

From a competitive standpoint, Bionic operated in a dense and convergent market. ASPM as a category gained traction as organizations recognized the impossible scale of modern vulnerability discovery without prioritization. Competitors included specialized ASPM vendors (Apiiro, ArmorCode), broader AppSec platforms (Snyk), and emerging runtime-aware security tools. Bionic's differentiation lay in the sophistication of its runtime context model and its ability to integrate behavior analytics with remediation workflows. However, larger security platforms have increasingly incorporated runtime context and posture analytics, creating competitive pressure and category convergence.

Bionic's acquisition by CrowdStrike is strategically coherent: it adds application-layer context and remediation orchestration to CrowdStrike's endpoint and cloud security platform, supporting more comprehensive software risk management. The outcome also reflects realistic market dynamics: strong technical innovation and clear product-market fit in an emerging category do not guarantee sustained independence, particularly in cybersecurity where platform consolidation and buyer preference for integrated solutions dominate.

Dual-Use Assessment

Military & Commercial Applications

Runtime-aware application security posture management is dual-use for both enterprise software risk reduction and defense-adjacent software assurance. Commercial organizations use ASPM to prioritize remediation across thousands of vulnerabilities and reduce exploitable exposure in production systems. Defense and critical infrastructure sectors require the same capability: identifying which vulnerabilities pose genuine operational risk in mission-critical software. Bionic's technology directly supports secure software development practices, vulnerability triage in complex stacks, and software assurance workflows applicable to both commercial and defense environments. The acquisition by CrowdStrike—a major security infrastructure provider to both commercial and government customers—validates and extends this dual-use relevance through a trusted defense-adjacent channel.

Strategic Fit Assessment

Bionic is not currently strategically relevant: it was acquired by CrowdStrike in 2023 and is no longer independent. However, the company represents a valuable case study of successful deep-tech commercialization in application security. Bionic demonstrated strong product-market fit in the ASPM category, validated customer demand for runtime-aware vulnerability prioritization, achieved significant traction, and was acquired at a strategic premium by a tier-one security platform vendor. The acquisition outcome and CrowdStrike's integration of Bionic's technology into its platform confirm the commercial viability and strategic relevance of the core innovation pattern. for strategic readers in application security, software assurance, or dual-use DefenseTech, Bionic's technology architecture and market validation remain instructive as patterns for context-aware security analytics and remediation orchestration.

Strategic Value to U.S.-Israel Alliance

Bionic's core innovation—embedding runtime behavior and production context into vulnerability triage—addresses a critical pain point in modern software security: the explosion of vulnerability discovery vastly outpaces remediation capacity. By linking active application behavior to vulnerability relevance, the platform reduced false positives and enabled efficient prioritization in complex, cloud-native stacks. This technology pattern is directly applicable to both commercial software assurance and defense-relevant software supply chain security. CrowdStrike's acquisition and integration demonstrates confidence in the market durability of context-aware vulnerability prioritization. For strategic analysis, Bionic exemplifies the convergence of application-layer security, behavioral analytics, and DevSecOps—a critical capability as organizations manage software risk in distributed environments.

Key Technologies

  • Runtime behavior analytics and mapping
  • Production context for vulnerability triage
  • Application-centric risk prioritization
  • Automated remediation orchestration and guidance
  • Cloud-native stack integration and visibility
  • Behavioral anomaly and exploit-readiness detection

Use Cases & Applications

  • Reducing exploitable vulnerability surface in production applications
  • Prioritizing AppSec remediation by genuine business and operational risk
  • Secure software operations and compliance in cloud-native and containerized stacks
  • Software assurance in regulated commercial sectors (financial services, healthcare)
  • Mission-critical software risk assessment and triage in defense-adjacent environments
  • Supply chain security and dependency risk management with runtime context
  • DevSecOps automation and CI/CD pipeline vulnerability orchestration

Sources and verification

This profile is based on public-source research, Claw & Talon curation, and editorial judgment. Inclusion does not imply endorsement, partnership, investment, or a recommendation to transact. Readers should still confirm current status, customers, funding, and product claims before relying on this profile.

Public sources

The links below are visible public references used for source discipline around company identity, status, funding, customer, acquisition, public-company, or other material claims where available.

  • Official website Primary public reference for company identity, positioning, and current web presence.
  • Profile update timestamp Last updated in the Claw & Talon database on Apr 28, 2026.

Investor Lens

What this entry is

Acquired asset

Why it may matter

Bionic may matter as a Cybersecurity entry with not currently an investable standalone company for Israeli technology research.

How an independent investor should read this

Not currently an investable standalone company. Read this profile as a starting point for independent verification, not as a recommendation or suitability assessment.

Evidence to verify

  • Verify current status
  • Verify technical claims
  • Verify regulatory/export-control issues

Main investor questions

  • Is this entry a benchmark, buyer, ecosystem node, acquired asset, or strategic reference rather than a live startup opportunity?
  • What does this reference clarify about buyers, sector structure, public-market context, or strategic demand?
  • Does the dual-use claim map to actual commercial and government/defense/resilience buyer evidence?
  • What evidence would change the thesis or show that the profile is stale?

What not to infer

  • Inclusion does not imply endorsement.
  • Inclusion does not imply allocation availability or current fundraising.
  • Scores do not indicate investment suitability or expected returns.
  • Strategic importance does not automatically imply venture return potential.

Diligence questions

  • What evidence verifies Bionic's current customer traction, deployment status, and revenue concentration?
  • Which technical claims are independently demonstrable today, and which remain roadmap or pilot-stage assertions?
  • Where does the product create real defense, intelligence, critical-infrastructure, or emergency-response value beyond ordinary commercial adoption?
  • How does the platform integrate into existing SOC, cloud, identity, or compliance workflows without adding operational burden?
  • Is the company a live venture opportunity, a mature strategic reference, an acquired asset, or primarily a market-mapping entry?

Related sector

See the Cybersecurity sector page for market context, related subcategories, and other Israeli companies in this part of the database.

Need a diligence readout?

Use the profile and related checklists as a starting point. If the decision needs more context, request a company screen, founder-call prep, diligence memo, or sector readout.